炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 21世纪经济报道记者季媛媛 国内吸入制剂市场长期被跨国药企垄断，长风药业用十八年时间成功撬开了一道裂缝。 10月8日，长风药业股份有限公司（股票代码：02652.HK）正式在港交所主板挂牌交易。本次 IPO 联席保荐人为中信证券、招银国际，发行价为每股 14.75港元。长风药业8日开盘价达48港元/股，大涨...
Source Link炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 21世纪经济报道记者季媛媛 国内吸入制剂市场长期被跨国药企垄断，长风药业用十八年时间成功撬开了一道裂缝。 10月8日，长风药业股份有限公司（股票代码：02652.HK）正式在港交所主板挂牌交易。本次 IPO 联席保荐人为中信证券、招银国际，发行价为每股 14.75港元。长风药业8日开盘价达48港元/股，大涨...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.